Chief Financial Officer

Vice President, Clinical Research and Regulatory Affairs

Arcellx resumed with a Buy at Stifel

Arcellx assumed with a Neutral at Cantor Fitzgerald

Arcellx Insider Sold Shares Worth $1,709,723, According to a Recent SEC Filing

Arcellx's Chief Medical Officer Sells Shares

Medical Science Liaison

Arcellx is a public, clinical-stage biotechnology company focused on innovative immunotherapies for cancer treatment. The Medical Science Liaison will serve as a key scientific resource for healthcare professionals and internal stakeholders, facilitating relationships and engaging in medical education to support the company's transformative therapies.

Medical Science Liaison (Mid-Atlantic)

Chief People Officer

Senior Medical Science Liaison

Sign up with Google

Sign in with Google